Mattarollo SR - Search Results

1

Therapeutic vaccination with 4-1BB co-stimulation eradicates mouse acute myeloid leukemia.

Kerage D, Soon MSF, Doff BL, Kobayashi T, Nissen MD, Lam PY, Leggatt GR, Mattarollo SR. Kerage D, et al. Among authors: mattarollo sr. Oncoimmunology. 2018 Jul 26;7(10):e1486952. doi: 10.1080/2162402X.2018.1486952. eCollection 2018. Oncoimmunology. 2018. PMID: 30288351 Free PMC article.

2

NKT cell-targeted vaccination plus anti-4-1BB antibody generates persistent CD8 T cell immunity against B cell lymphoma.

Kobayashi T, Doff BL, Rearden RC, Leggatt GR, Mattarollo SR. Kobayashi T, et al. Among authors: mattarollo sr. Oncoimmunology. 2015 Jan 7;4(3):e990793. doi: 10.4161/2162402X.2014.990793. eCollection 2015 Mar. Oncoimmunology. 2015. PMID: 25949907 Free PMC article.

3

Immunosuppressive roles of natural killer T (NKT) cells in the skin.

McKee SJ, Mattarollo SR, Leggatt GR. McKee SJ, et al. Among authors: mattarollo sr. J Leukoc Biol. 2014 Jul;96(1):49-54. doi: 10.1189/jlb.4RU0114-001R. Epub 2014 May 5. J Leukoc Biol. 2014. PMID: 24799605 Review.

4

Control of B-cell lymphoma by therapeutic vaccination and acquisition of immune resistance is independent of direct tumour IFN-gamma signalling.

Rearden R, Sah A, Doff B, Kobayashi T, McKee SJ, Leggatt GR, Mattarollo SR. Rearden R, et al. Among authors: mattarollo sr. Immunol Cell Biol. 2016 Jul;94(6):554-62. doi: 10.1038/icb.2016.9. Epub 2016 Jan 20. Immunol Cell Biol. 2016. PMID: 26786233

5

Therapeutic Efficacy of 4-1BB Costimulation Is Abrogated by PD-1 Blockade in a Model of Spontaneous B-cell Lymphoma.

McKee SJ, Doff BL, Soon MS, Mattarollo SR. McKee SJ, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2017 Mar;5(3):191-197. doi: 10.1158/2326-6066.CIR-16-0249. Epub 2017 Jan 23. Cancer Immunol Res. 2017. PMID: 28115358

6

β-Adrenergic Signaling Impairs Antitumor CD8⁺ T-cell Responses to B-cell Lymphoma Immunotherapy.

Nissen MD, Sloan EK, Mattarollo SR. Nissen MD, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2018 Jan;6(1):98-109. doi: 10.1158/2326-6066.CIR-17-0401. Epub 2017 Nov 16. Cancer Immunol Res. 2018. PMID: 29146881

7

Natural killer cell metabolism.

Kobayashi T, Mattarollo SR. Kobayashi T, et al. Among authors: mattarollo sr. Mol Immunol. 2019 Nov;115:3-11. doi: 10.1016/j.molimm.2017.11.021. Epub 2017 Nov 24. Mol Immunol. 2019. PMID: 29179986 Review.

8

B cell lymphoma progression promotes the accumulation of circulating Ly6Clo monocytes with immunosuppressive activity.

McKee SJ, Tuong ZK, Kobayashi T, Doff BL, Soon MS, Nissen M, Lam PY, Keane C, Vari F, Moi D, Mazzieri R, Leggatt G, Gandhi MK, Mattarollo SR. McKee SJ, et al. Among authors: mattarollo sr. Oncoimmunology. 2017 Dec 18;7(2):e1393599. doi: 10.1080/2162402X.2017.1393599. eCollection 2018. Oncoimmunology. 2017. PMID: 29308328 Free PMC article.

9

NKT Cell-Driven Enhancement of Antitumor Immunity Induced by Clec9a-Targeted Tailorable Nanoemulsion.

Lam PY, Kobayashi T, Soon M, Zeng B, Dolcetti R, Leggatt G, Thomas R, Mattarollo SR. Lam PY, et al. Among authors: mattarollo sr. Cancer Immunol Res. 2019 Jun;7(6):952-962. doi: 10.1158/2326-6066.CIR-18-0650. Epub 2019 May 3. Cancer Immunol Res. 2019. PMID: 31053598

10

Invariant Natural Killer T Cells in Immune Regulation of Blood Cancers: Harnessing Their Potential in Immunotherapies.

Lam PY, Nissen MD, Mattarollo SR. Lam PY, et al. Among authors: mattarollo sr. Front Immunol. 2017 Oct 23;8:1355. doi: 10.3389/fimmu.2017.01355. eCollection 2017. Front Immunol. 2017. PMID: 29109728 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

48 results

Search Page

Filters